← All stocks

GILD vs NVO

Gilead Sciences Inc. Common Stock vs Novo Nordisk A/S Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

GILD
Gilead Sciences Inc. Common Stock
Healthcare
150.56
186.13B
NVO
Novo Nordisk A/S Common Stock
Healthcare
39.80
191.03B
ACCE scores
GILD
NVO
Composite score
Out of 100
64
63
Growth
76
19
Value
40
91
Quality
55
96
Momentum
83
45
Valuation
GILD
NVO
Price
150.56
39.80
Market cap
186.13B
191.03B
Trailing P/E
0.00
10.73
Forward P/E
15.29
13.33
EV / EBITDA
116.03
9.06
Dividend yield
2.1%
4.2%
Profitability
GILD
NVO
ROE
-20.7%
59.8%
Net margin
-10.6%
35.4%
Debt / equity
1.10
0.67
Free cash flow
9.46B
28.99B
Growth
GILD
NVO
Revenue growth (YoY)
10.2%
2.1%
Earnings growth (YoY)
54.8%
-20.6%
Analyst target
158.15
46.80
See full analysis